The fourth quarter of 2016 has been a roller coaster for the life science industry, with investors celebrating the presidential election results a tad preemptively. As a result, stock prices have soared and then nearly immediately tanked.
San Diego’s drugmakers and other public firms in the life science space have suffered a touch more than the biotech industry as a whole. The Nasdaq Biotech Index showed a 7 percent drop in stock prices, while San Diego firms collectively fell over 15 percent.
The San Diego Business Journal reviewed the quarterly performance of nearly 30 local life science firms, and saw a lot of shaky performances across the board.
Which San Diego firms had the most extreme ups and downs during this election-dominated quarter? Here’s a look at the biggest winners and losers.
